Last reviewed 2026-04-20 · How we verify

Vessel

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Vascular graft thrombosis
• Pyrexia (fever)
• Pain
• Anastomotic stenosis
• Vascular graft rupture or anastomotic failure
• Vascular graft infection

Serious adverse events

• Vascular graft thrombosis
• Vascular graft rupture or anastomotic failure
• Vascular graft infection
• Anastomotic stenosis

Key clinical trials

• Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
• Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (PHASE3)
• Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES) (NA)
• Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (PHASE2, PHASE3)
• Cera™ Vascular Plug System Post-Market Clinical Follow-Up
• Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction
• SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations (PHASE3)
• Coronary Flow During Rapid Heart Rates

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Vessel CI brief — competitive landscape report
• Vessel updates RSS · CI watch RSS
• Value Outcomes Ltd. portfolio CI